| __timestamp | Sarepta Therapeutics, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 9757000 | 580415000 |
| Thursday, January 1, 2015 | 1253000 | 1032336000 |
| Friday, January 1, 2016 | 5421000 | 1702177000 |
| Sunday, January 1, 2017 | 154584000 | 2488652000 |
| Monday, January 1, 2018 | 301034000 | 3047597000 |
| Tuesday, January 1, 2019 | 380833000 | 4162821000 |
| Wednesday, January 1, 2020 | 540099000 | 6205683000 |
| Friday, January 1, 2021 | 701887000 | 7574400000 |
| Saturday, January 1, 2022 | 933013000 | 8930700000 |
| Sunday, January 1, 2023 | 1243336000 | 9869200000 |
| Monday, January 1, 2024 | 11020100000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, Vertex Pharmaceuticals Incorporated and Sarepta Therapeutics, Inc. have emerged as key players. Over the past decade, Vertex has demonstrated a remarkable revenue growth trajectory, increasing its annual revenue by over 1,600% from 2014 to 2023. This growth is largely attributed to its innovative treatments for cystic fibrosis, which have dominated the market.
Conversely, Sarepta Therapeutics, known for its pioneering work in genetic medicine, has seen its revenue grow by an impressive 12,600% during the same period. This surge is driven by its advancements in therapies for rare neuromuscular diseases.
While Vertex's revenue in 2023 reached nearly $9.9 billion, Sarepta's revenue stood at approximately $1.2 billion. This comparison highlights the diverse strategies and market focuses of these two biotech giants, each carving out a unique niche in the healthcare industry.
Revenue Insights: Johnson & Johnson and Sarepta Therapeutics, Inc. Performance Compared
AbbVie Inc. and Vertex Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
Revenue Showdown: Sanofi vs Vertex Pharmaceuticals Incorporated
Breaking Down Revenue Trends: Vertex Pharmaceuticals Incorporated vs Grifols, S.A.
Breaking Down Revenue Trends: Vertex Pharmaceuticals Incorporated vs Merus N.V.
Vertex Pharmaceuticals Incorporated or Mesoblast Limited: Who Leads in Yearly Revenue?
Breaking Down Revenue Trends: Teva Pharmaceutical Industries Limited vs Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Sarepta Therapeutics, Inc. or PTC Therapeutics, Inc.: Who Leads in Yearly Revenue?
Who Generates More Revenue? Sarepta Therapeutics, Inc. or Arrowhead Pharmaceuticals, Inc.
Sarepta Therapeutics, Inc. or Geron Corporation: Who Leads in Yearly Revenue?
Who Generates More Revenue? Sarepta Therapeutics, Inc. or Celldex Therapeutics, Inc.